Raul Ravelo
Radiation Oncology · Miami, FLNPI 1780672923
Payments from drug & device makers
Across 154 payments — averaging $23.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$421
- AstraZeneca$289
- Johnson & Johnson$280
- Pfizer$238
- Myriad Genetic Laboratories, Inc.$188
- Regeneron Healthcare Solutions, Inc.$171
- plus $2K from 34 others
What the payments were for
- Food & beverage$3,646100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 19 | $421 |
| AstraZeneca(2 entities) | 11 | $289 |
| Johnson & Johnson | 14 | $280 |
| Pfizer | 12 | $238 |
| Myriad Genetic Laboratories, Inc. | 5 | $188 |
| Regeneron Healthcare Solutions, Inc. | 7 | $171 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $159 |
| Bayer | 7 | $149 |
| Medical Device Business Services, Inc. | 1 | $122 |
| AbbVie | 6 | $112 |
| Daiichi Sankyo Inc. | 4 | $98 |
| Novocure Inc. | 3 | $94 |
| Boston Scientific | 4 | $91 |
| Palette Life Sciences, Inc. | 2 | $81 |
| Novartis | 3 | $77 |
| Servier Pharmaceuticals LLC | 3 | $73 |
| Stemline Therapeutics Inc. | 4 | $72 |
| Tempus AI, Inc | 3 | $70 |
| Incyte Corporation | 3 | $67 |
| Azurity Pharmaceuticals, Inc. | 3 | $64 |
| Pharmacosmos Therapeutics Inc. | 3 | $64 |
| Sanofi | 3 | $57 |
| Dendreon Pharmaceuticals LLC | 2 | $54 |
| Sobi, Inc | 2 | $50 |
| Eisai Inc. | 2 | $48 |
| Genentech USA, Inc. | 2 | $46 |
| Adaptive Biotechnologies Corporation | 2 | $46 |
| Pharmaand GmbH | 2 | $43 |
| Tolmar, Inc. | 2 | $43 |
| Amneal Pharmaceuticals LLC | 2 | $40 |
| Lilly USA, LLC | 2 | $37 |
| Napo Pharmaceuticals Inc | 1 | $28 |
| TELA Bio, Inc. | 1 | $27 |
| Seagen Inc. | 1 | $24 |
| Beigene USA, Inc. | 1 | $24 |
| Coherus Oncology, Inc. | 1 | $23 |
| Taiho Oncology, Inc. | 1 | $23 |
| Gilead | 1 | $21 |
| EMD Serono, Inc. | 1 | $20 |
| Agios Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,646 in reported general payments places this provider in the 75th percentile of 465 radiation oncology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lupron DepotLeuprolide Acetate | 39 | $232,905 |
| Tamsulosin Hcl | 30 | $210 |
| Triamcinolone Acetonide | 12 | $131 |
| Finasteride | 11 | $46 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLupron Depot | $112 | $232,90539 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 465 radiation oncology providers in Florida.
Other radiation oncology in Miami
- Charles KunosMiami$3.2M
- Rupesh KotechaMiami$2M
- Michael ChuongMiami$868K
- Marcus BredelMiami$578K
- Adeel KaiserMiami$409K
- Matthew AbramowitzMiami$308K
- Marcio FagundesMiami$274K
- Benjamin SpielerMiami$93K
- Minesh MehtaMiami$88K
- Brandon MahalMiami$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.